TREACE JOHN T. (Chief Executive Officer) purchased 2.5% of their position (150K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $767.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/14/2024ACC: 0000950170-24-059854
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+150K
Net shares
Net buyer
$767.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+150K
Price / share
$5.12
Trade value
$767.80K
% of position
2.5%
5/14/2024
6.09M→6.24M
Total
Net shares
+150K
Net value
$767.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2024 | P · Purchase | +150K | $5.12 | $767.80K | 2.5% | 6.09M | 6.24M |
| Total | +150K | $767.80K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned408.82K
Common Stock
IndirectShares owned1.60M
Common Stock
IndirectShares owned1.47M
Common Stock
IndirectShares owned1.84M
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 408.82K | Indirect |
| Common Stock | 1.60M | Indirect |
| Common Stock | 1.47M | Indirect |
| Common Stock | 1.84M | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported